Professional
Added to YB: 2024-08-22
Pitch date: 2024-07-20
DXCM [bullish]
DexCom, Inc.
-41.71%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
Market Cap
$23.5B
Pitch Price
$112.76
Price Target
N/A
Dividend
N/A
EV/EBITDA
21.49
P/E
33.52
EV/Sales
5.04
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
Invesco Health Care Fund Portfolio Holding: DexCom, Inc.
DXCM: Strong growth in CGM devices, new patients, better margins & raised guidance. Sentiment down on inventory destocking, health plan switching & vendor cyberattack disrupting Medicaid claims. Wearable glucose monitors for diabetes treatment.
Read full article (1 min)